Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Attila Zalatnai
Ecdysteroids Sensitize MDR and Non-MDR Cancer Cell Lines to Doxorubicin, Paclitaxel, and Vincristine but Tend to Protect Them From Cisplatin
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Related publications
Sinomenine Sensitizes Multidrug-Resistant Colon Cancer Cells (Caco-2) to Doxorubicin by Downregulation of MDR-1 Expression
PLoS ONE
Multidisciplinary
Tuberculosis: Current Strategies to Control MDR
International Journal of Medical Research and Review
Ginkgo May Sensitize Ovarian Cancer Cells to Cisplatin
Integrative Cancer Therapies
Oncology
Alternative Medicine
Complementary
Guanylate-Binding Protein-1 Protects Ovarian Cancer Cell Lines but Not Breast Cancer Cell Lines From Killing by Paclitaxel
Biochemical and Biophysical Research Communications
Biochemistry
Cell Biology
Molecular Biology
Biophysics
Chalcones Repressed the AURKA and MDR Proteins Involved in Metastasis and Multiple Drug Resistance in Breast Cancer Cell Lines
Molecules
Organic Chemistry
Molecular Medicine
Analytical Chemistry
Theoretical Chemistry
Pharmaceutical Science
Medicine
Drug Discovery
Chemistry
Physical
ErbB3 Expression Predicts Sensitivity to Elisidepsin Treatment: In�vitro Synergism With Cisplatin, Paclitaxel and Gemcitabine in Lung, Breast and Colon Cancer Cell Lines
International Journal of Oncology
Cancer Research
Oncology
Genetic Polymorphisms and Ovarian Cancer Risk and Response to Paclitaxel/Cisplatin Chemotherapy
Hereditary Cancer in Clinical Practice
Oncology
Genetics
Halocynthiaxanthin and Peridinin Sensitize Colon Cancer Cell Lines to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Magnetic Nanoparticles Sensitize McF-7 Breast Cancer Cells to Doxorubicin-Induced Apoptosis
World Journal of Surgical Oncology
Surgery
Oncology
